https://cysticfibrosisnewstoday.com/news/all-cf-patients-dosed-with-bx004-phage-therapy-p-aeruginosa-infections/
Data from the first part of the Phase 1b/2a study showed BX004 reduced the number of bacteria in the lungs with no signs of resistance.
Create an account
or login to join the discussion